荷兰胰腺癌组强制审计前6年胰腺手术结局
该全国性队列研究纳入2014—2019年荷兰胰腺癌审计中连续接受胰十二指肠切除术(PD)或远端胰腺切除术的患者,比较三个时间段结局。PD后失败救援(FTR)从13%降至7.4%,院内死亡率从4.1%降至2.4%,尽管高龄及高合并症患者增多;远端胰腺切除术的改善无统计学意义。
要点
- PD后FTR从13%降至7.4%,院内死亡率从4.1%降至2.4%。
- PD后教科书结局与大并发症率保持稳定。
- 远端胰腺切除术的FTR与死亡率改善无统计学意义。
核心结论
- 强制全国审计前6年,PD后院内死亡率和FTR改善,尽管高危患者增多。
- 多种协作努力可能促成上述改善。
研究设计与样本
- 共纳入5345例,其中PD 4227例,远端胰腺切除术1118例。
- 比较2014—2015、2016—2017、2018—2019三个时间段,采用多水平多变量逻辑回归分析。
主要发现
- PD后FTR从13%降至7.4%(OR 0.64,95%CI 0.50-0.80,P<0.001)。
- PD后院内死亡率从4.1%降至2.4%(OR 0.68,95%CI 0.54-0.86,P=0.001)。
- PD患者中年龄>75岁比例从18%升至22%(P=0.006),ASA评分≥3从19%升至31%(P<0.001),Charlson合并症评分≥2从24%升至34%(P<0.001)。
- PD后教科书结局从57%至55%(P=0.283),大并发症从31%至33%(P=0.207),并发症相关ICU入住从13%降至9%(P=0.002)。
- 远端胰腺切除术后FTR从8.8%降至5.9%(OR 0.65,95%CI 0.30-1.37,P=0.253),院内死亡率从1.6%降至1.3%(OR 0.88,95%CI 0.45-1.72,P=0.711)。
临床怎么用
- PD术后应关注失败救援与院内死亡率的持续改善,同时警惕高危患者比例上升。
- 远端胰腺切除术后的结局改善尚不明确,仍需针对性优化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe outcome after pancreatic surgery in the first 6 years of a mandatory nationwide audit. BACKGROUND: Within the Dutch Pancreatic Cancer Group, efforts have been made to improve outcome after pancreatic surgery. These include collaborative projects, clinical auditing, and implementation of an algorithm for early recognition and management of postoperative complications. However, nationwide changes in outcome over time have not yet been described. METHODS: This nationwide cohort study included consecutive patients after pancreatoduodenectomy (PD) and distal pancreatectomy from the mandatory Dutch Pancreatic Cancer Audit (January 2014-December 2019). Patient, tumor, and treatment characteristics were compared between 3 time periods (2014-2015, 2016-2017, and 2018-2019). Short-term surgical outcome was investigated using multilevel multivariable logistic regression analyses. Primary endpoints were failure to rescue (FTR) and in-hospital mortality. RESULTS: Overall, 5345 patients were included, of whom 4227 after PD and 1118 after distal pancreatectomy. After PD, FTR improved from 13% to 7.4% [odds ratio (OR) 0.64, 95% confidence interval (CI) 0.50-0.80, P <0.001] and in-hospital mortality decreased from 4.1% to 2.4% (OR 0.68, 95% CI 0.54-0.86, P =0.001), despite operating on more patients with age >75 years (18%-22%, P =0.006), American Society of Anesthesiologists score ≥3 (19%-31%, P <0.001) and Charlson comorbidity score ≥2 (24%-34%, P <0.001). The rates of textbook outcome (57%-55%, P =0.283) and major complications remained stable (31%-33%, P =0.207), whereas complication-related intensive care admission decreased (13%-9%, P =0.002). After distal pancreatectomy, improvements in FTR from 8.8% to 5.9% (OR 0.65, 95% CI 0.30-1.37, P =0.253) and in-hospital mortality from 1.6% to 1.3% (OR 0.88, 95% CI 0.45-1.72, P =0.711) were not statistically significant. CONCLUSIONS: During the first 6 years of a nationwide audit, in-hospital mortality and FTR after PD improved despite operating on more high-risk patients. Several collaborative efforts may have contributed to these improvements.
引用
- Suurmeijer JA, Henry AC, Bonsing BA, et al. Outcome of Pancreatic Surgery During the First 6 Years of a Mandatory Audit Within the Dutch Pancreatic Cancer Group. Ann Surg. 2022. PMID: 35866656. doi:10.1097/SLA.0000000000005628
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。